Quoin Pharmaceuticals, Ltd.

NasdaqCM:QNRX Stock Report

Market Cap: US$3.1m

Quoin Pharmaceuticals Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

NasdaqCM:QNRX Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
10 Sep 24BuyUS$23,205Gordon DunnIndividual28,856US$0.91
04 Sep 24BuyUS$25,426Michael MyersIndividual32,572US$0.80
04 Sep 24BuyUS$28,737Denise CarterIndividual37,735US$0.80
04 Sep 24BuyUS$3,490Michael MyersIndividual5,322US$0.66
07 Jun 24SellUS$217Dennis LangerIndividual297US$0.73

Insider Trading Volume

Insider Buying: QNRX insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of QNRX?
Owner TypeNumber of SharesOwnership Percentage
Individual Insiders123,5702.45%
Institutions165,0813.27%
General Public4,761,06994.3%

Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 411.5%.

Top Shareholders

Top 12 shareholders own 5.72% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
0.94%
Michael Myers
47,252US$29.3k0%no data
0.93%
Denise Carter
47,092US$29.2k0%no data
0.77%
Renaissance Technologies LLC
38,691US$24.0k13.1%no data
0.63%
Two Sigma Securities, LLC, Asset Management Arm
31,854US$19.7k35.8%no data
0.57%
Gordon Dunn
28,856US$17.9k0%no data
0.5%
Virtu Financial LLC, Asset Management Arm
25,165US$15.6k0%no data
0.5%
Raymond James Financial Services Advisors, Inc.
25,119US$15.6k0%no data
0.45%
UBS Asset Management AG
22,821US$14.1k274%no data
0.41%
Rhumbline Advisers Ltd Partnership
20,786US$12.9k40.5%no data
0.013%
JPMorgan Chase & Co, Private Banking and Investment Banking Investments
645US$399.80%no data
0.0063%
A. Culverwell
317US$196.60%no data
0.001%
Dennis Langer
53US$32.90%no data